By Counterforce Health Team in Oxervate (cenegermin) —

How Long Does It Take to Get Oxervate (Cenegermin) Approved by UnitedHealthcare in Pennsylvania? Complete Timeline & Appeals Guide

Answer Box: Getting Oxervate Approved by UnitedHealthcare in Pennsylvania

Timeline: UnitedHealthcare typically decides prior authorization requests within 5-14 business days, though OptumRx's automated system can approve qualifying requests in under 30 seconds. Key requirements: Stage 2 or 3 neurotrophic keratitis diagnosis, documented failure of at least one OTC artificial tear product, and ophthalmologist consultation. First step today: Have your eye doctor submit the PA request through UHCprovider.com with complete step therapy documentation. If denied, Pennsylvania's new external review program has a 50% success rate overturning insurance denials.

Table of Contents

What Affects Oxervate Approval Timing

Several factors influence how quickly UnitedHealthcare approves Oxervate (cenegermin) in Pennsylvania:

Benefit Type: Commercial plans through OptumRx typically process faster than Medicare Advantage plans due to different regulatory requirements. Self-funded employer plans may have customized criteria that extend review times.

Documentation Completeness: The most significant factor affecting approval speed is whether your initial submission includes all required elements. UnitedHealthcare requires documented failure of at least one OTC artificial tear product before considering Oxervate.

Clinical Complexity: Stage 2 neurotrophic keratitis cases with clear epithelial defects typically process faster than complex Stage 3 cases requiring additional clinical justification.

Note: OptumRx has implemented automated prior authorization through PreCheck, reducing median approval times from 8.5 hours to under 30 seconds for qualifying medications.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before your ophthalmologist submits the prior authorization request, gather these required elements:

Clinical Documentation:

  • Confirmed Stage 2 or 3 neurotrophic keratitis diagnosis with corneal photography
  • Slit-lamp examination findings with measurements
  • Corneal sensitivity testing results (cotton-tipped applicator or Cochet-Bonnet aesthesiometry)
  • Documentation of underlying cause (diabetes, herpes simplex, etc.)

Step Therapy Requirements:

Provider Information:

  • Ophthalmologist or optometrist consultation documentation
  • Prescriber DEA and NPI numbers
  • Treatment plan specifying 6 drops daily for 8 weeks

Submission to Initial Review (1-5 Days)

Standard Processing Timeline

UnitedHealthcare processes most prior authorization requests within 5-14 business days. However, OptumRx's automated system can approve requests in under 30 seconds when all criteria are clearly met.

What Reviewers Check First

  1. Patient eligibility: Active UnitedHealthcare coverage and age ≥2 years
  2. Diagnosis verification: ICD-10 codes for neurotrophic keratitis (H16.23- series)
  3. Step therapy compliance: Documentation of artificial tear failure
  4. Provider qualification: Ophthalmology or optometry specialty verification

Submission Methods

Online Portal (Fastest): Healthcare providers submit through UHCprovider.com using the Prior Authorization and Notification tool.

Phone Submission: 1-800-711-4555 for standard or expedited requests.

Fax: 1-844-403-1027 for non-urgent submissions.

Additional Information Requests (1-7 Days)

If UnitedHealthcare requests additional information, you'll receive notification within 2-3 business days of submission. Common requests include:

  • Enhanced clinical photographs: Before/after images showing epithelial defect progression
  • Detailed failure documentation: More specific artificial tear trial information
  • Specialist consultation notes: Complete ophthalmology examination records
Tip: Respond to information requests within 48 hours to avoid processing delays. Most "pending" requests can be resolved through the provider portal upload feature.

Decision Window & Outcomes

Typical Approval Scenarios

Immediate Approval (Same day): Cases with complete documentation meeting all step therapy requirements through OptumRx's automated system.

Standard Approval (5-10 business days): Most cases requiring human review but meeting clinical criteria.

Conditional Approval (7-14 business days): Approvals with quantity limits, duration restrictions, or specific pharmacy requirements.

Reading Your Approval Letter

Approved requests will specify:

  • Quantity limits: Typically one 8-week treatment course initially
  • Pharmacy restrictions: May require specialty pharmacy dispensing
  • Duration: Usually 60-90 days for initial approval
  • Renewal requirements: Documentation needed for subsequent courses

If Denied: Pennsylvania Appeal Options

UnitedHealthcare Internal Appeals

Level 1 Internal Appeal: Submit within 180 days of denial notice. Include:

  • Copy of original denial letter
  • Additional clinical documentation addressing denial reasons
  • Medical necessity letter from prescribing ophthalmologist

Expedited Appeals: Available for urgent cases; decision within 72 hours for Medicare plans.

Pennsylvania External Review Program

Pennsylvania launched its Independent External Review Program in January 2024 with impressive results: 50% of appealed denials were overturned in the first year.

Process:

  1. Complete UnitedHealthcare's internal appeals first
  2. Submit external review request within 4 months of final internal denial
  3. Independent review organization (IRO) decides within 45 days
  4. No cost to consumers; decisions are binding on insurers

How to File: Visit pa.gov or call the Pennsylvania Insurance Department at 1-877-881-6388.

Renewal Cycles & Maintenance

When to Request Renewal

Submit renewal requests 2-3 weeks before your current authorization expires. UnitedHealthcare typically approves initial 8-week courses, requiring new prior authorization for additional treatment cycles.

Documentation for Renewals

  • Clinical response assessment with corneal photography
  • Justification for continued therapy or re-treatment
  • Updated examination findings
  • Treatment adherence confirmation

Timeline Milestones

Milestone Timeline Action Required
Documentation gathering 1-2 days Clinic collects step therapy records
PA submission Same day Provider submits via portal/phone
Initial review 1-5 days Automated or manual processing
Additional info request 2-3 days If documentation incomplete
Final decision 5-14 days Approval/denial notification
Internal appeal 30-60 days If denied, submit appeal
External review 45 days Pennsylvania IRO decision

Time-Saving Tips

Use Provider Portals: UHCprovider.com submissions process faster than fax or phone requests.

Bundle Evidence: Submit all required documentation in a single submission rather than piecemeal responses.

Leverage Automation: Ensure your request meets OptumRx's automated criteria for under-30-second approvals.

Direct Specialty Routing: Have your ophthalmologist submit requests directly rather than routing through primary care.

Common Denial Reasons & Solutions

Denial Reason Solution
Insufficient step therapy documentation Provide specific artificial tear names, dates, frequencies, and failure rationale
Missing Stage 2/3 diagnosis confirmation Submit corneal photography with measurements and slit-lamp findings
Non-ophthalmology prescriber Transfer prescription to ophthalmologist or optometrist
Inadequate medical necessity Include detailed treatment history and clinical progression notes

FAQ

How long does UnitedHealthcare PA take in Pennsylvania? Standard prior authorization decisions take 5-14 business days, though OptumRx's automated system can approve qualifying requests in under 30 seconds.

What if Oxervate is non-formulary on my plan? Oxervate requires prior authorization on most UnitedHealthcare plans but is typically covered with appropriate documentation. Non-formulary status doesn't prevent coverage with medical necessity approval.

Can I request an expedited appeal in Pennsylvania? Yes, expedited appeals are available for urgent medical situations, with decisions typically within 72 hours for Medicare plans.

Does step therapy apply if I failed artificial tears in another state? Yes, documented artificial tear failures from other states satisfy UnitedHealthcare's step therapy requirements as long as you provide complete pharmacy records and clinical notes.

What happens if Pennsylvania's external review overturns my denial? The insurer must immediately provide coverage, including retroactive coverage if you paid out-of-pocket during the appeal process.

Counterforce Health helps patients and clinicians navigate complex insurance approvals by turning denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and payer policies to create point-by-point rebuttals that align with each insurer's specific requirements, significantly improving approval rates for specialty medications like Oxervate.

From our advocates: We've seen Oxervate approvals expedited when providers include side-by-side corneal photographs showing epithelial defect measurements before and after artificial tear trials. This visual documentation often satisfies reviewers immediately, avoiding back-and-forth requests for additional clinical information.

Need help with your UnitedHealthcare appeal? Counterforce Health specializes in transforming insurance denials into successful approvals through targeted, evidence-based appeal strategies.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual policy terms and clinical circumstances. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For assistance with Pennsylvania insurance appeals, contact the Pennsylvania Insurance Department at 1-877-881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.